Anti-VEGF agents: As appealing targets in the setting of COVID-19 treatment in critically ill patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-VEGF agents: As appealing targets in the setting of COVID-19 treatment in critically ill patients
Authors
Keywords
Anti-VEGF therapy, COVID-19, Critically Ill Patients, Inflammation, SARS-CoV-2, Therapeutic Target
Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 101, Issue -, Pages 108257
Publisher
Elsevier BV
Online
2021-10-19
DOI
10.1016/j.intimp.2021.108257
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients
- (2021) Lili Li et al. Frontiers in Immunology
- Calming the inflammatory storm in severe COVID-19 infections: Role of biologics- A narrative review
- (2021) David Banji et al. SAUDI PHARMACEUTICAL JOURNAL
- Efficacy and tolerability of bevacizumab in patients with severe Covid-19
- (2021) Jiaojiao Pang et al. Nature Communications
- Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials
- (2021) Timothy Arthur Chandos Snow et al. INTENSIVE CARE MEDICINE
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
- (2020) Qiurong Ruan et al. INTENSIVE CARE MEDICINE
- COVID-19: towards understanding of pathogenesis
- (2020) Wei Cao et al. CELL RESEARCH
- The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
- (2020) Francesca Coperchini et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak
- (2020) Xi-Xi Yin et al. ACS Chemical Neuroscience
- SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
- (2020) Víctor J. Costela-Ruiz et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Thrombosis and COVID-19 pneumonia: the clot thickens!
- (2020) Laura C. Price et al. EUROPEAN RESPIRATORY JOURNAL
- Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?
- (2020) Alice Huertas et al. EUROPEAN RESPIRATORY JOURNAL
- Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
- (2020) Alessio Mazzoni et al. JOURNAL OF CLINICAL INVESTIGATION
- COVID ‐19 acute respiratory distress syndrome ( ARDS ): clinical features and differences from typical pre‐ COVID ‐19 ARDS
- (2020) Peter G Gibson et al. MEDICAL JOURNAL OF AUSTRALIA
- Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities
- (2020) Puja Mehta et al. Lancet Respiratory Medicine
- Immune Response, Inflammation, and the Clinical Spectrum of COVID-19
- (2020) Luis F. García Frontiers in Immunology
- Microvascular dysfunction in COVID-19: the MYSTIC study
- (2020) Alexandros Rovas et al. ANGIOGENESIS
- SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia
- (2020) Aubin Moutal et al. PAIN
- An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies
- (2020) Hin Fung Tsang et al. Expert Review of Anti-Infective Therapy
- Vascular endothelial growth factor signaling in development and disease
- (2018) Sinem Karaman et al. DEVELOPMENT
- Risk of bleeding associated with antiangiogenic monoclonal antibodies bevacizumab and ramucirumab: a meta-analysis of 85 randomized controlled trials
- (2018) Bingkun Xiao et al. OncoTargets and Therapy
- Sunitinib-induced hypothyroidism predicts progression-free survival in metastatic renal cell carcinoma patients
- (2017) Anna Buda-Nowak et al. MEDICAL ONCOLOGY
- Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension
- (2015) B. Ranchoux et al. CIRCULATION
- Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805
- (2015) N. B. Haas et al. CLINICAL CANCER RESEARCH
- Vascular endothelial cell Toll-like receptor pathways in sepsis
- (2015) Samira Khakpour et al. Innate Immunity
- Influenza Virus Infection Induces Platelet-Endothelial Adhesion Which Contributes to Lung Injury
- (2015) Michael G. Sugiyama et al. JOURNAL OF VIROLOGY
- VEGF-VEGFR Signals in Health and Disease
- (2014) Masabumi Shibuya Biomolecules & Therapeutics
- Vascular Endothelial Growth Factor in Acute Lung Injury and Acute Respiratory Distress Syndrome
- (2013) S. Barratt et al. RESPIRATION
- Role of bevacizumab in colorectal cancer growth and its adverse effects: A review
- (2013) Efstathios T Pavlidis WORLD JOURNAL OF GASTROENTEROLOGY
- Interleukin-6 induces vascular endothelial growth factor expression and promotes angiogenesis through apoptosis signal-regulating kinase 1 in human osteosarcoma
- (2012) Huey-En Tzeng et al. BIOCHEMICAL PHARMACOLOGY
- Thyroid Dysfunction in Patients Treated With Sunitinib or Sorafenib
- (2012) Julia Clemons et al. Clinical Genitourinary Cancer
- Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases
- (2012) M. Shibuya JOURNAL OF BIOCHEMISTRY
- The Double Edged Sword of Bleeding and Clotting from VEGF Inhibition in Renal Cancer Patients
- (2012) Guru Sonpavde et al. Current Oncology Reports
- The Role of Vascular Endothelial Growth Factor in Wound Healing
- (2008) Philip Bao et al. JOURNAL OF SURGICAL RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now